Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Product containing nafoxidine (medicinal product) |
Is a |
agent antinéoplasique |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing nafoxidine (medicinal product) |
Is a |
Product containing estrogen receptor antagonist (product) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing nafoxidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Estrogen receptor antagonist |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing nafoxidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Nafoxidine |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing nafoxidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hormone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing nafoxidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
hormones et leurs métabolites et précurseurs |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing nafoxidine (medicinal product) |
Is a |
Product containing synthetic antiestrogen |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing nafoxidine (medicinal product) |
Is a |
Medicinal product categorized by structure (product) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing nafoxidine (medicinal product) |
Plays role |
Antineoplastic therapeutic role |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing nafoxidine (medicinal product) |
Is a |
Product containing hormone receptor antagonist (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|